|
pubmed:abstractText |
Activating mutations of the BRAF oncogene play a central role in the development of various cancer types, but their role in human adrenocortical tumors is unknown. At variance, activating mutations of another oncogene, CTNNB1, which encodes beta-catenin, have been shown to be common events in both benign and malignant adrenocortical tumors.
|
|
pubmed:affiliation |
Department of Histology, Microbiology, and Medical Biotechnologies, University of Padua, Padua, Italy.
|
